Hearing Loss Clinical Trials
2 recruiting trials for Hearing Loss. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Hearing Loss clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Johns Hopkins University (1), University of Florida (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is HEARS-NPS device (device, 1 trial), followed by HEARS-NPS program, Cymba Conchae stimulation.
Track Hearing Loss trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
This randomized controlled trial study aims to evaluate a revised hearing care intervention for older adults with Alzheimer's Disease and Related Dementias (ADRD). The...
Improving Speech in Noise Using Noninvasive Stimulation
Traumatic brain injury, a common injury in military service personnel, often leads to poor processing of speech in noisy environments. The goal of the current study is to better...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Hearing Loss, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Hearing Loss, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Hearing Loss, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.